End-stage liver disease (ESLD) is a life-threatening clinical syndrome that markedly increases mortality in patients with infections. In patients with ESLD, infections can induce or aggravate the occurrence of liver decompensation. Consequently, infections are among the most common complications of disease progression. There is a lack of working procedure for early diagnosis and appropriate management for patients with ESLD complicated by infections as well as local and international guidelines or consensus. This consensus assembled up-to-date knowledge and experience across Chinese colleagues, providing data on principles as well as working procedures for the diagnosis and treatment of patients with ESLD complicated by infections.

Consensus;Diagnosis;End stage of liver disease;Infection;Therapy

Ning Qin;Chen Tao;Wang Guiqiang;Xu Dong;Yu Yanyan;Mao Qing;Li Taisheng;Li Lanjuan;Li Jun;Lu Xiaoju;Li Jiabin;Li Zhiwei;Zhang Wenhong;Xiao Yonghong;Meng Qinghua;Mi Yuqiang;Shang Jia;Yu Yunsong;Zhao Yingren;Zhao Caiyan;Zhao Hong;Huang Jianrong;Peng Jie;Tang Hong;Tang Xiaoping;Hu Jinhua;Hu Bijie;Guo Wei;Zheng Bo;Chen Baiyi;Zhang Yuexin;Wei Jia;Sheng Jifang;Chen Zhi;Wang Minggui;Xie Qing;Wang Yuming;Wang Fu-Sheng;Hou Jinlin;Duan Zhongping;Wei Lai;Jia Jidong;Chinese Society of Infectious Disease of Chinese Medical Association

Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China;Department of Infectious Diseases, Southwest Hospital, Army Medical University, Chongqing 400038, China;Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China;State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China;Department of Infectious Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China;Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China;Department of Infectious Diseases, First Affiliated Hospital of Anhui Medical University, Hefei 230031, China;Department of Infectious Diseases, Shengjing Hospital, Affiliated Hospital of China Medical University, Shenyang 110801, China;Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China;Department of Severe Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Nankai University Second People’s Hospital, Tianjin 300071, China;Department of Infectious Disease, People’s Hospital of Henan Province, Zhengzhou 450003, China;Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China;Department of Infectious Diseases, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China;Department of Infectious Diseases, Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China;State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;Research Institute of Infectious Diseases, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou 510060, China;Liver Failure Treatment and Research Center, The Fifth Medical Center, China PLA General Hospital, Beijing 100039, China;Department of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai 200032, China;Institute of Clinical Pharmacology, Peking University First Hospital, Beijing 100034, China;Department of Infectious Diseases, The First Hospital of China Medical University, Shenyang 110002, China;Center of Infectious Diseases, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China;Department of Infectious Disease, The Second People’s Hospital, Kunming 650201, China;Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China;Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University Hepatology Institute, Peking University People’s Hospital, Beijing 100044, China;Liver Research Center, Beijing Friendship Hospital, Capital Medial University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis & National Clinical Research Center for Digestive Diseases, Beijing 100050, China

感染性疾病和免疫（英文）

[1]Ning Qin;Chen Tao;Wang Guiqiang;Xu Dong;Yu Yanyan;Mao Qing;Li Taisheng;Li Lanjuan;Li Jun;Lu Xiaoju;Li Jiabin;Li Zhiwei;Zhang Wenhong;Xiao Yonghong;Meng Qinghua;Mi Yuqiang;Shang Jia;Yu Yunsong;Zhao Yingren;Zhao Caiyan;Zhao Hong;Huang Jianrong;Peng Jie;Tang Hong;Tang Xiaoping;Hu Jinhua;Hu Bijie;Guo Wei;Zheng Bo;Chen Baiyi;Zhang Yuexin;Wei Jia;Sheng Jifang;Chen Zhi;Wang Minggui;Xie Qing;Wang Yuming;Wang Fu-Sheng;Hou Jinlin;Duan Zhongping;Wei Lai;Jia Jidong;Chinese Society of Infectious Disease of Chinese Medical Association-.Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infections)[J].感染性疾病和免疫（英文）,2022(03):168-178

Expert,Consensus,Diagnosis,Treatment,End,Stage,Liver,Disease,Complicated,Infections,stage,liver,disease,ESLD,life,threatening,clinical,syndrome,that,markedly,increases,mortality,patients,infections,can,induce,aggravate,occurrence,decompensation,Consequently,are,among,most,common,complications,progression,There,lack,working,early,diagnosis,appropriate,management,complicated,by,well,local,international,guidelines,consensus,This,assembled,up,date,knowledge,experience,across,Chinese,colleagues,providing,data,principles,procedures,treatment,Therapy

0.585217